Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
M.D. Anderson Cancer Center
Ionis Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
University of Miami
Silence Therapeutics plc
M.D. Anderson Cancer Center
PharmaEssentia
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc.
PharmaEssentia
City of Hope Medical Center
RWTH Aachen University
Italfarmaco
AbbVie